Three Arizona Headwinds in One Week

Last week the CDC’s National Vital Statistics System released its provisional drug overdose data through May 3, 2026. The national headline was the best one we’ve had in a decade: overdose deaths are down roughly 14 percent year-over-year, the lowest figure since October 2019, before the pandemic-era spike. Oregon is down 35 percent. North Carolina is down 34. New York, Alabama — all sharply lower.

Arizona is up 17.31 percent. New Mexico is up 21.30 percent. Almost every other state moved with the national curve. Two states moved against it. Both of them are ours and our neighbor’s.

In the same week that data came out, two other things happened in Arizona that are worth understanding together. A state audit found that the Department of Corrections may have unlawfully spent fifty million dollars in opioid settlement money. And Phoenix’s ordinance criminalizing harm-reduction activity in city parks — including needle exchange and the distribution of fentanyl test strips — got its enforcement date set: June 1, 2026.

Three pieces of news. One week. One state. They tell a story.

What the CDC data actually shows

The May 13 release is provisional — CDC will revise it as later death certificates land — but the directional signal is unambiguous. The national trajectory is the most encouraging since fentanyl became dominant. Forty-eight states are tracking with that trajectory.

Arizona and New Mexico are the holdouts, and the gap is widening, not narrowing. We covered the early version of this divergence on May 14 and May 16. What’s new this week is that the provisional numbers now run through May 3, 2026, and the divergence has not corrected. It has accelerated.

The most plausible drivers — and ones our team has been tracking through the SAMHSA SOR funding picture and the Alivia 360 settlement-distribution story — are well documented: a tighter, more contaminated drug supply in the Southwest corridor (cychlorphine and medetomidine are now confirmed in eight states), uneven naloxone saturation outside Maricopa and Pima, and Arizona’s persistent rank near 49th in behavioral health access. None of these is new. What’s new is that the rest of the country has begun to bend its curve and we have not.

The settlement-money problem

On May 13, KJZZ reported that the state Auditor General found the Arizona Department of Corrections, Rehabilitation and Reentry may have unlawfully spent 50.9 million dollars in opioid settlement funds. ADCRR used the money to treat incarcerated people for hepatitis C — a legitimate health need — but did not provide documentation linking those infections to intravenous opioid use, as the One Arizona Agreement requires for that pot of money.

The consequence isn’t just possible repayment. It’s that ADCRR could be cut off from future settlement disbursements, and the political case for tight oversight of every dollar in the eighteen-year, 1.215-billion-dollar payout just got measurably stronger.

For people watching this from the outside, the headline reads as a corrections-department issue. For anyone trying to deploy treatment infrastructure inside Arizona, it is something else. It is evidence that the bottleneck is no longer money. The bottleneck is the capacity to spend the money on what the settlement agreement actually requires, document it, and report outcomes well enough to keep the pipeline open. The agencies and organizations that can do that — that can show overdose reversals, treatment entries, time-to-treatment, and downstream retention — are the ones that will keep getting funded. The ones that can’t, won’t.

The Phoenix parks ordinance

The third item is the one with the closest deadline. Phoenix’s ordinance prohibiting harm-reduction distribution in city parks, including syringe service activity and the handing-out of fentanyl test strips, becomes enforceable on June 1, 2026. The ordinance defines “medical treatment” broadly enough to cover any activity that involves “needles, syringes, other medical sharps, or produces medical waste,” and adds food distribution to the same restricted list.

Phoenix’s ordinance prohibiting harm-reduction distribution in city parks, including syringe service activity and the handing-out of fentanyl test strips, becomes enforceable on June 1, 2026.

Arizona only legalized syringe service programs a few years ago. The reason groups like Sonoran Prevention Works, Shot in the Dark, and Southwest Recovery Alliance operate in city parks is not that they prefer parks; it is that the people they serve — disproportionately unhoused, disproportionately polysubstance — are there. Pushing distribution out of parks does not move the population. It moves the encounter. Many encounters will simply not happen.

Harm-reduction leaders have been clear about what they expect to see: more overdoses, including more fatal ones, concentrated in the very neighborhoods Phoenix is trying to make less visible. The state’s overdose reversal infrastructure — the one that, on average, has been catching more events than it has been losing — depends on these encounters. Removing the encounter point without replacing it is not a neutral act.

Why these three things belong in the same article

Taken individually, each item is a discrete policy or data event. Taken together, they describe a single dynamic.

Arizona has the crisis. The CDC data confirms it. Arizona has the money — 1.215 billion dollars over eighteen years from the settlement. And Arizona, in this particular week, is showing every sign of being unable to deploy that money where the science says it works. The Department of Corrections may have routed it past the agreement’s guardrails. The City of Phoenix is making the most cost-effective category of intervention — needle exchange, naloxone distribution, test-strip distribution — formally harder to do.

This is what “ground zero” looks like in practice. Not a single bad number. A pattern of bottlenecks that compounds.

Why this matters for people in recovery

If you live in Arizona and you or someone you love uses drugs, the practical changes you should know about between now and the end of summer are these. Free naloxone is still available statewide; Shot in the Dark ships it free anywhere in Arizona, no questions asked. After June 1, the Phoenix groups that hand out naloxone and test strips in city parks will need to do so in different locations — but the supply has not gone away. And if a settlement-funded program in your area changes hands or shuts down because of the audit fallout, the resources don’t disappear; they get redirected. Knowing where to look matters more than ever.

We’re tracking all three of these threads — the data, the settlement-dollar accountability story, and the harm-reduction policy shifts — on the Arizona Watch page. Our Naloxone & Harm Reduction Hub will go live ahead of the Phoenix ordinance taking effect, with location-aware distribution-point lookups so that whatever the city of Phoenix decides about its parks, no one in Arizona is more than a short drive from a working supply.

If you or someone you love is in crisis, call or text 988. If you’ve witnessed an overdose, naloxone is available free across Arizona.